Thursday 22nd August 2019

Understanding vascular involvement in systemic sclerosis

In her talk at SRUK’s regional conference in Cambridge, Dr Robyn Domsic discussed a variety of topics that are crucial to understanding vascular involvement and expert recommendations on management.

Read Article

Tuesday 20th August 2019

Oral and dental involvement in scleroderma: What happens and how can it be managed?

Recently, a poll was run online to understand what oral and dental complications of scleroderma impact those living with the condition the most. We’ve selected some questions from the poll to answer here.

Read Article

Wednesday 14th August 2019

Meet Our Fundraisers Shining A Spotlight On The Importance Of Early Detection

As a charity, our community of fundraisers are crucial to the work that we do. We are shining a spotlight on two fundraisers who are particularly passionate about the importance of early detection.

Read Article

Tuesday 6th August 2019

Recent findings from SRUK-funded study of wax-bath treatments for scleroderma published

The musculoskeletal features of systemic sclerosis (SSc) are a major cause of disability, causing limitations to movement and function. The study aim was to compare the effects of daily hand exercises with or without daily home wax bath hand treatment in patients with SSc.

Read Article

Friday 2nd August 2019

Why Early Detection of Scleroderma Matters

For patients with scleroderma, early detection is crucial. It can make a world of difference when fighting a disease as unpredictable as this one. In order to highlight the importance of early detection, we have collated anecdotes from our community members about their experiences with early detection, or lack thereof.

Read Article

Tuesday 28th August 2018

Cause, detection and treatment: research we fund and why

Funding important research into medical conditions is a crucial way in which medical research charities improve people’s lives. When a condition is rare like scleroderma, then that research becomes even more vital.

Read Article

Friday 24th August 2018

Remembering ‘CREST’: useful acronym or dangerous diagnostic hinderance?

Slightly older ears may remember the days of ‘CREST’, the now outdated term for Scleroderma. But what did ‘CREST’ mean? Why was it used? And why was the term abandoned in mainstream medical practice?

Read Article

Monday 20th August 2018

Why does Raynaud’s Phenomenon affect more women? Estrogen could be the answer

It’s been well established that women are more likely to be affected by Raynaud’s phenomenon than men but why? Let's look into the reasons behind this.

Read Article

Friday 17th August 2018

Beating Scleroderma and Raynaud’s with AI: Microsoft and SRUK team up to advance research

SRUK will be working with Microsoft to develop wearable technology to further our research into the conditions.

Read Article

Thursday 24th August 2017

New blood test may diagnose scleroderma

A new blood test has been developed that it is hoped will be used to diagnose scleroderma in the future.

Read Article